ArticleSmall science2026
Neuroprotective Effects of Cerium Oxide Nanoparticles During Spaceflight.
Article in Small science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The spaceflight environment exposes biological systems to microgravity and cosmic radiation, which are factors known to induce oxidative stress and neurodegenerative processes. As the central nervous system is highly susceptible to disruptions in redox homeostasis, the development of effective strategies to safeguard astronaut health and cognitive function during extended space missions has become imperative. In this study, we investigate cerium oxide nanoparticles (nanoceria, NC) as an antioxidant agent for human neuron-like cells aboard the International Space Station. Nanoceria demonstrated excellent biocompatibility, strong antioxidant properties, and the ability to stimulate neurite extension under both Earth gravity and simulated microgravity. Following the return of the samples to Earth, transcriptomic analyses revealed that nanoceria effectively counteracted the detrimental transcriptional alterations triggered by spaceflight stressors, thereby maintaining neuronal homeostasis. Importantly, the expression of genes involved in antioxidant defense, mitochondrial activity, and dopamine metabolism remained stable in nanoceria-treated neurons, in contrast to the dysregulation observed in untreated controls. These findings position cerium oxide nanoparticles as promising antioxidant neuroprotectants for long-duration space missions and related neurodegenerative conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.